The documents indicated Mortimer D.A. Sackler emailed two other directors in the company that the pharmaceutical industry “had become far too volatile and risky” for the family to invest nearly all of its wealth in. The revelation suggests that the Sacklers had long been concerned about the financial risks of keeping its ownership stake in a drug company.
The newly released complaint, filed previously by the Connecticut attorney general against Purdue Pharma and some of the Sacklers, is one of the more than 1,600 lawsuits Purdue Pharma faces for its alleged role in fueling the opioid crisis in the U.S.
Read the full report here.
More articles on pharmacy:
Insys execs guilty of opioid racketeering scheme
Walgreens shaking up C-suite
Generic drugmakers could thrive in a recession, Moody’s says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
